A detailed history of Armistice Capital, LLC transactions in Nevro Corp stock. As of the latest transaction made, Armistice Capital, LLC holds 3,624,000 shares of NVRO stock, worth $33.9 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
3,624,000
Previous 3,176,000 14.11%
Holding current value
$33.9 Million
Previous $68.3 Million 23.43%
% of portfolio
0.71%
Previous 0.97%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $6.07 Million - $9.31 Million
448,000 Added 14.11%
3,624,000 $52.3 Million
Q4 2023

Feb 13, 2024

SELL
$14.18 - $22.31 $3.97 Million - $6.25 Million
-280,000 Reduced 8.1%
3,176,000 $68.3 Million
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $20 Million - $28.4 Million
1,100,000 Added 46.69%
3,456,000 $66.4 Million
Q2 2023

Aug 14, 2023

BUY
$22.62 - $39.32 $53.3 Million - $92.6 Million
2,356,000 New
2,356,000 $59.9 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $331M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.